Arrowhead Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Good morning. Welcome everyone to the forty-fourth annual JPMorgan Healthcare Conference. My name is Matt Bannon, and I'm a banker here at JPM. I am very pleased to be introducing our first presenting company of the day, Arrowhead Pharmaceuticals, and presenting on behalf of Arrowhead, we have the President and CEO Chris Anzalone.
Before, we kick off, I'll just remind folks that we will have time for Q&A at the end of the session. So to ask a question, just raise your hand, we'll get you a mic, or you can ask it through the online portal, and I'll relay the question on your behalf. So, without further ado, Chris.
Well, thanks very much to JP Morgan for inviting us and thank you all for coming, and starting off this busy week. I'm sort of reminded of the, of a tsunami, right? When a tsunami comes, the wave doesn't come immediately, there is the tide recedes and so we are in that receding tide right now. And so good luck for the rest of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
